Dan,
In your last post you said
“BRK will not engage in wholesale development drilling of the DSU's... unless they change their minds for whatever reason, and then I am certain DP will state that now the primary monetisation pathway is full BRK development”
How do you think this would affect investor sentiment towards the company, when it’s already at an all time low because of uncertainty around the monetisation?
- Forums
- ASX - By Stock
- BRK
- Banter and General Comments .. BRK
Banter and General Comments .. BRK, page-8488
-
- There are more pages in this discussion • 3,344 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRK (ASX) to my watchlist
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.50M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.0¢ | $168.7K | 15.37M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 18081297 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 2200000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 18081297 | 0.010 |
16 | 9169112 | 0.009 |
5 | 514099 | 0.008 |
3 | 2850000 | 0.007 |
2 | 350000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 2200000 | 2 |
0.012 | 15439004 | 24 |
0.013 | 25625122 | 24 |
0.014 | 21378997 | 18 |
0.015 | 5316049 | 11 |
Last trade - 15.48pm 09/08/2024 (20 minute delay) ? |
Featured News
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
BRK (ASX) Chart |